Skip to main content


Fig. 3 | Gynecological Surgery

Fig. 3

From: HMG-CoA reductase inhibitor lovastatin upregulates plasminogen activator production through RhoA-signaling in peritoneal cell line Met5A

Fig. 3

Tissue-type plasminogen activator mRNA level in Met5A cells exposed to lovastatin, geranylgeranyl pyrophosphate (GGPP), or C3. Total RNA was extracted for real-time polymerase chain reaction analysis from the cells exposed to lovastatin (1 µM), lovastatin and GGPP (1 µM), C3 (1 µg/ml), or lovastatin, GGPP, and C3 for 18 h. As relative to control ± SD of three independent experiments performed in duplicate determination. *P < 0.05 versus control

Back to article page